APA

Levine R. L., Wadleigh M., Sternberg D. W., Wlodarska I., Galinsky I., Stone R. M., DeAngelo D. J., Gilliland D. G. & Cools J. (20050401). KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). : Leukemia.

Chicago

Levine R L, Wadleigh M, Sternberg D W, Wlodarska I, Galinsky I, Stone R M, DeAngelo D J, Gilliland D Gary and Cools J. 20050401. KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). : Leukemia.

Harvard

Levine R. L., Wadleigh M., Sternberg D. W., Wlodarska I., Galinsky I., Stone R. M., DeAngelo D. J., Gilliland D. G. and Cools J. (20050401). KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). : Leukemia.

MLA

Levine R L, Wadleigh M, Sternberg D W, Wlodarska I, Galinsky I, Stone R M, DeAngelo D J, Gilliland D Gary and Cools J. KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). : Leukemia. 20050401.